In the realm of clinical trials, the process of selecting appropriate sites to conduct research is critical for the success of a study. The consequences of poor site selection can be dire, leading to delays in recruitment, compromised data quality, increased costs, and even regulatory risks. Despite the advancements in data-driven approaches utilizing AI systems and diverse data sources, challenges persist in how site selection processes are structured and evaluated. There is often a disconnect between the perspectives of sponsors/CROs and clinical sites, with the former focusing on quantitative indicators while the latter possess valuable local operational knowledge but may lack resources for thorough feasibility analyses.
A novel systems-based framework has been developed to move beyond mere prediction in site selection and delve into understanding why certain decisions succeed or fail. This shift in focus enables targeted interventions that can enhance recruitment efforts, data quality, and overall trial efficiency. The framework facilitates a systematic evaluation of whether site selection decisions yield the intended outcomes across the trial lifecycle. Unlike traditional approaches that primarily aim to enhance selection methodologies, this framework provides tools to diagnose the reasons behind the success or failure of selections, pinpointing specific deficiencies in data interpretation and application.
The framework is underpinned by a multi-layered approach that categorizes site evaluation into inputs, dynamic capabilities, and outputs, drawing from systems modeling principles. By utilizing three primary data sources—literature reviews, analysis of feasibility questionnaires, and interviews with industry professionals—the framework offers a comprehensive view of site selection assessment. Through this approach, decision-makers can better infer a site’s capabilities and expected outputs based on available data before making recommendations, with ongoing monitoring enabling targeted interventions and systematic learning throughout the trial.
One of the key findings from the analysis of existing literature and practical applications is the prevalence of inaccurate feasibility projections, a recurring concern mentioned in multiple studies. This leads to a circular reasoning problem where sites estimate their enrollment capacity based on incomplete information, complicating the evaluation process for sponsors/CROs. Patient recruitment challenges, trial advertising, historical performance utilization, and protocol management were also identified as significant factors affecting site performance, indicating the complexity of the site selection landscape.
Interviews with industry professionals shed light on how site selection practices are evolving to adapt to complex protocols, emphasize patient diversity, and integrate emerging technologies. Case studies highlighted how targeted interventions focusing on enhancing sites’ dynamic capabilities, rather than merely expanding resources, can lead to significant improvements in enrollment trajectories and overall trial performance. The framework not only addresses current improvement areas but also acknowledges the need for transparent and systematic processes in site selection decisions, emphasizing accountability, consistency, and downstream monitoring.
Key Takeaways:
– The site selection process in clinical trials is crucial for study success, with poor choices leading to delays, compromised data quality, and increased costs.
– A systems-based framework offers a holistic approach to site selection assessment, moving beyond prediction to understand why selections succeed or fail.
– Inaccurate feasibility projections and patient recruitment challenges are among the primary concerns affecting site performance.
– Collaborative partnerships focusing on enhancing sites’ dynamic capabilities are recommended over traditional resource-based interventions for improving trial outcomes.
Tags: clinical trials, downstream, digital twins, regulatory
Read more on appliedclinicaltrialsonline.com